AbbVie Inc.
Sem negociações
Sem negociações
Títulos de dívida corporativa
Abaixo está a lista de títulos AbbVie Inc., classificados pelo menor rendimento. Investidores costumam optar pelos títulos de uma empresa pela maior estabilidade em momentos de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo | YTW % | Preço % | Cupom % | Vencimento | Montante em circulação | Valor de face | Classificação S&P | Classificação da Fitch | Emissor |
|---|---|---|---|---|---|---|---|---|---|
 ACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6,59% | 86,71% | 4,550% | 2035-03-15 | 107,65 M USD | 1.000,00 USD | NR | — | Allergan Funding SCS |
 ABBV6474595AbbVie Inc. 6.1% 15-SEP-2066 | 6,19% | 99,76% | 6,100% | 2066-09-15 | — | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6474596AbbVie Inc. 6.0% 15-SEP-2056 | 6,10% | 99,61% | 6,000% | 2056-09-15 | — | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064 | 6,09% | 91,12% | 5,500% | 2064-03-15 | 1,5 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6323042AbbVie Inc. 5.65% 15-MAR-2066 | 6,07% | 93,45% | 5,650% | 2066-03-15 | 500 M USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054 | 6,01% | 91,88% | 5,400% | 2054-03-15 | 3 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6323041AbbVie Inc. 5.55% 15-MAR-2056 | 6,00% | 93,66% | 5,550% | 2056-03-15 | 1,25 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049 | 6,00% | 78,13% | 4,250% | 2049-11-21 | 5,75 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055 | 5,99% | 94,27% | 5,600% | 2055-03-15 | 750 M USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048 | 5,98% | 86,25% | 4,875% | 2048-11-14 | 1,75 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045 | 5,98% | 86,31% | 4,750% | 2045-03-15 | 827,09 M USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| US287YAW9AbbVie Inc. 4.45% 14-MAY-2046 | 5,95% | 82,62% | 4,450% | 2046-05-14 | 2 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| 4ABBAbbVie Inc. 4.7% 14-MAY-2045 | 5,92% | 86,22% | 4,700% | 2045-05-14 | 2,7 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044 | 5,85% | 94,34% | 5,350% | 2044-03-15 | 750 M USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044 | 5,82% | 88,75% | 4,850% | 2044-06-15 | 1,01 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| US00287YAM12AbbVie Inc. 4.4% 06-NOV-2042 | 5,82% | 85,20% | 4,400% | 2042-11-06 | 2,6 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042 | 5,82% | 87,99% | 4,625% | 2042-10-01 | 389,22 M USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039 | 5,57% | 85,91% | 4,050% | 2039-11-21 | 4 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6474383AbbVie Inc. 5.45% 15-SEP-2038 | 5,52% | 99,78% | 5,450% | 2038-09-15 | — | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6474384AbbVie Inc. 5.3% 15-SEP-2036 | 5,39% | 99,65% | 5,300% | 2036-09-15 | — | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6323043AbbVie Inc. 4.75% 15-MAR-2036 | 5,30% | 95,90% | 4,750% | 2036-03-15 | 1,5 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| US287YAV1AbbVie Inc. 4.3% 14-MAY-2036 | 5,26% | 92,71% | 4,300% | 2036-05-14 | 1 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035 | 5,26% | 95,07% | 4,550% | 2035-03-15 | 1,68 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| US287YAR0AbbVie Inc. 4.5% 14-MAY-2035 | 5,25% | 94,78% | 4,500% | 2035-05-14 | 2,5 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035 | 5,22% | 99,84% | 5,200% | 2035-03-15 | 1 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034 | 5,15% | 99,39% | 5,050% | 2034-03-15 | 3 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6474594AbbVie Inc. 5.05% 15-SEP-2033 | 5,14% | 99,63% | 5,050% | 2033-09-15 | — | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6322510AbbVie Inc. 4.4% 15-MAR-2033 | 5,06% | 96,22% | 4,400% | 2033-03-15 | 1,25 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6474593AbbVie Inc. 4.875% 15-SEP-2031 | 4,91% | 99,91% | 4,875% | 2031-09-15 | — | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6322511AbbVie Inc. 4.125% 15-MAR-2031 | 4,87% | 96,91% | 4,125% | 2031-03-15 | 1,25 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031 | 4,83% | 100,44% | 4,950% | 2031-03-15 | 2 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6474592AbbVie Inc. 4.65% 15-MAR-2030 | 4,75% | 99,69% | 4,650% | 2030-03-15 | — | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030 | 4,73% | 100,45% | 4,875% | 2030-03-15 | 1 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029 | 4,71% | 95,42% | 3,200% | 2029-11-21 | 5,44 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029 | 4,66% | 100,32% | 4,800% | 2029-03-15 | 2,5 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028 | 4,61% | 99,22% | 4,250% | 2028-11-14 | 1,75 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6474583AbbVie Inc. 4.5% 18-AUG-2028 | 4,50% | 99,94% | 4,500% | 2028-08-18 | — | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028 | 4,46% | 100,29% | 4,650% | 2028-03-15 | 1,25 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6322513AbbVie Inc. 3.775% 03-MAR-2028 | 4,46% | 98,96% | 3,775% | 2028-03-03 | 1,5 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027 | 4,29% | 100,29% | 4,800% | 2027-03-15 | 2,25 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026 | 4,08% | 99,67% | 2,950% | 2026-11-21 | 3,99 B USD | 1.000,00 USD | A− | — | AbbVie, Inc. |
| XS190919331Allergan Funding SCS 2.625% 15-NOV-2028 | 3,92% | 97,22% | 2,625% | 2028-11-15 | 72,11 M EUR | 1.000,00 EUR | NR | — | Allergan Funding SCS |
| XS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,85% | 95,46% | 2,125% | 2029-06-01 | 36,46 M EUR | 1.000,00 EUR | NR | — | Allergan Funding SCS |
| 4ABGAbbVie Inc. 1.25% 18-NOV-2031 | 3,32% | 90,09% | 1,250% | 2031-11-18 | 650 M EUR | 1.000,00 EUR | A− | — | AbbVie, Inc. |
| XS212591483AbbVie Inc. 2.625% 15-NOV-2028 | 3,29% | 98,56% | 2,625% | 2028-11-15 | 427,79 M EUR | 1.000,00 EUR | A− | — | AbbVie, Inc. |
| XS152090781AbbVie Inc. 2.125% 17-NOV-2028 | 3,20% | 97,68% | 2,125% | 2028-11-17 | 750 M EUR | 1.000,00 EUR | A− | — | AbbVie, Inc. |
| XS212591491AbbVie Inc. 2.125% 01-JUN-2029 | 3,09% | 97,42% | 2,125% | 2029-06-01 | 506,09 M EUR | 1.000,00 EUR | A− | — | AbbVie, Inc. |
| 4ABEAbbVie Inc. 0.75% 18-NOV-2027 | 2,94% | 97,29% | 0,750% | 2027-11-18 | 750 M EUR | 1.000,00 EUR | A− | — | AbbVie, Inc. |
| ABBV6474582AbbVie Inc. FRN 18-AUG-2028 | — | 100,06% | 0,000% | 2028-08-18 | — | 1.000,00 USD | — | — | AbbVie, Inc. |
| ABBV6322512AbbVie Inc. FRN 03-MAR-2028 | — | 100,06% | 4,115% | 2028-03-03 | 750 M USD | 1.000,00 USD | A− | — | AbbVie, Inc. |